Phase IB Sulindac Study for Women at High Risk for Breast Cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Sulindac (Primary)
- Indications Breast cancer
- Focus Pharmacokinetics
- 03 May 2013 Biomarkers information updated
- 26 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 26 Jun 2007 Status changed from recruiting to in progress.